New York State Teachers Retirement System Reduces Stock Position in CVS Health Corporation (NYSE:CVS)

New York State Teachers Retirement System cut its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 8.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,055,339 shares of the pharmacy operator's stock after selling 102,909 shares during the quarter. New York State Teachers Retirement System owned approximately 0.08% of CVS Health worth $71,499,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Essex Financial Services Inc. increased its holdings in CVS Health by 0.8% during the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after purchasing an additional 166 shares during the last quarter. McIlrath & Eck LLC increased its holdings in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares during the last quarter. Horizon Bancorp Inc. IN increased its holdings in CVS Health by 7.4% during the 1st quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock worth $177,000 after purchasing an additional 180 shares during the last quarter. Coppell Advisory Solutions LLC increased its holdings in CVS Health by 17.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock worth $56,000 after purchasing an additional 189 shares during the last quarter. Finally, Strategic Investment Advisors MI grew its position in shares of CVS Health by 2.3% in the 1st quarter. Strategic Investment Advisors MI now owns 8,466 shares of the pharmacy operator's stock worth $574,000 after acquiring an additional 194 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Stock Up 0.5%

CVS opened at $68.50 on Monday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The company has a market capitalization of $86.66 billion, a PE ratio of 16.35, a P/E/G ratio of 0.98 and a beta of 0.56. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The stock's fifty day moving average is $64.86 and its 200-day moving average is $60.93.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. CVS Health's revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter last year, the company posted $1.31 EPS. On average, equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CVS. Mizuho lifted their target price on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Wells Fargo & Company reiterated an "overweight" rating and issued a $84.00 target price (up previously from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Royal Bank Of Canada lifted their target price on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Cowen reiterated a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Finally, Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $74.75.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was purchased at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the transaction, the director now owns 12,007 shares of the company's stock, valued at $764,845.90. The trade was a 15.04% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.